HFSA AHFTC Board Certification Review 2024

HFSA AHFTC Board Certification Review 2024 OnDemand

Introduction

The HFSA AHFTC Board Certification Review 2024 OnDemand program from the Heart Failure Society of America provides an intensive and board-focused review of advanced heart failure, transplant cardiology, mechanical circulatory support, and contemporary heart failure management. Developed specifically for clinicians preparing for the ABIM Advanced Heart Failure and Transplant Cardiology (AHFTC) certification examinations, this comprehensive educational program combines expert-led lectures, interactive board-style discussions, case-based learning, and evidence-informed clinical reviews aligned with the ABIM AHFTC blueprint.

The curriculum covers the full spectrum of modern heart failure medicine, including HFrEF, HFpEF, pulmonary hypertension, inherited and infiltrative cardiomyopathies, myocarditis, transplant immunology, mechanical circulatory support, cardiogenic shock, arrhythmia management, and advanced device therapies. This file-based listing does not provide an HFSA Learning Center account, publisher question-bank access or live participation.

Designed for both board preparation and advanced clinical education, the program emphasizes practical patient management, hemodynamic reasoning, advanced therapies, transplant medicine, and evidence-informed cardiovascular care relevant to modern advanced heart failure practice.

Publisher Program and File Scope

HFSA AHFTC Board Certification Review 2024 study materials support independent review of advanced heart failure and transplantation.

The original HFSA program advertised the resources below; publisher-platform features are not included with this file-based listing, and file completeness is not independently verified:

• 13 pre-recorded educational presentations
• Full recordings of live board review sessions
• Downloadable slide decks
• Question bank for self-assessment
• Recommended reading list
• Board-style practice discussions
• Advanced heart failure and transplant cardiology educational resources
• Flexible OnDemand playback access with 2x viewing option

These materials support comprehensive board preparation and advanced cardiovascular clinical review.

Why This Course Is Important

Advanced heart failure and transplant cardiology represent some of the most complex areas of cardiovascular medicine, requiring clinicians to integrate hemodynamics, pharmacotherapy, transplant immunology, pulmonary hypertension management, mechanical circulatory support, arrhythmia management, and advanced device therapy into highly specialized patient care environments.

At the same time, the growing prevalence of advanced heart failure, cardiogenic shock, inherited cardiomyopathies, and transplant-related complications has increased the need for clinicians with specialized expertise in advanced heart failure management and multidisciplinary cardiovascular care.

The HFSA AHFTC Board Certification Review 2024 addresses these challenges through a highly structured educational framework focused on board-relevant knowledge, evidence-informed management strategies, and practical advanced heart failure decision-making. The curriculum mirrors the complexity of modern AHFTC practice while helping clinicians prepare effectively for ABIM certification and recertification examinations.

What Participants Will Learn

Participants completing this program will strengthen their understanding of advanced heart failure, transplant cardiology, and mechanical circulatory support through board-focused cardiovascular education.

Learning objectives include:

• Understanding advanced hemodynamics and cardiopulmonary exercise testing in heart failure
• Applying guideline-directed medical therapy for HFrEF and HFpEF
• Managing pulmonary hypertension and cardiorenal syndromes
• Recognizing inherited, inflammatory, infiltrative, and restrictive cardiomyopathies
• Evaluating hospitalized heart failure patients and advanced heart failure phenotypes
• Understanding transplant immunology, sensitization, PRA, and rejection mechanisms
• Managing immunosuppressive therapies and transplant complications
• Applying mechanical circulatory support and ECMO strategies
• Managing cardiogenic shock and advanced heart failure emergencies
• Understanding arrhythmia management and device therapy in heart failure patients
• Preparing for ABIM AHFTC board certification examinations using board-style learning methods

The curriculum integrates heart failure medicine, transplant cardiology, electrophysiology, hemodynamics, and critical care cardiology into a comprehensive educational experience.

Original Program Topics & Lectures

Day 1 (Friday, July 12, 2024)

Opening Sessions

Welcome and HFSA Introduction — Nancy Sweitzer, MD, PhD, FHFSA and Maria Rosa Costanzo, MD, FHFSA

Live ABIM Style Question Session — Nancy Sweitzer, MD, PhD, FHFSA and Maria Rosa Costanzo, MD, FHFSA

Hemodynamics & Heart Failure Physiology

Hemodynamics in HF II — James C. Fang, MD, FHFSA

Guideline-Directed Medical Therapy

Optimal Medical Therapy for HFrEF 1 — Mark Drazner, MD, MSc, FHFSA

Optimal Medical Therapy for HFrEF 2 — Mark Drazner, MD, MSc, FHFSA

Cardiorenal & Functional Assessment

Cardio Renal Failure Interactions in Heart Failure

Assessment of Functional Capacity Including Cardiopulmonary Exercise Testing — Gregory Lewis, MD

HFpEF & Comorbidities

HFpEF: Epidemiology, Risk Factors, Diagnosis, Management (For the Boards) — Sanjiv Shah, MD

Management of Comorbidities in Heart Failure: Iron Deficiency/Anemia — Gregory Lewis, MD

Pulmonary Hypertension

Pulmonary Hypertension: Classification and Initial Evaluation — Jonathan Rich, MD, FHFSA

Pulmonary Hypertension: Treatment — Jonathan Rich, MD, FHFSA

Specific Etiologies of Heart Failure

Specific Etiologies of HF 1: HCM — Jane Wilcox, MD, MSc, FHFSA

Specific Etiologies of HF 2: Other Inherited HF Syndromes — Jane Wilcox, MD, MSc, FHFSA

Specific Etiologies of HF 3: Infiltrative Disorders and Restrictive CMP — Sanjiv Shah, MD

Day 2 (Saturday, July 13, 2024)

Advanced Heart Failure & Inflammatory Cardiomyopathies

Specific Etiologies of HF 4: Myocarditis and Inflammatory Cardiomyopathies — Maria Rosa Costanzo, MD, FHFSA

Management of the Hospitalized HF Patient — Maria Rosa Costanzo, MD, FHFSA

Advanced Heart Failure: Defining the Phenotype and Patient Selection for Advanced Therapies — Nancy Sweitzer, MD, PhD, FHFSA

Heart Transplantation & Immunology

Immunology: The Basics, PRA, Sensitization, Crossmatch — Sean Pinney, MD, FHFSA

Rejection: Cellular and Antibody Mediated — Sean Pinney, MD, FHFSA

Heart Transplant, Clinical Outcomes and Complications — Michelle Kittleson, MD, PhD, FHFSA

Managing Immunosuppression and Drugs — Michelle Kittleson, MD, PhD, FHFSA

Special Populations & Shock

Pregnancy in HF — Kathryn Lindley, MD

Cardiogenic Shock Management — Nancy Sweitzer, MD, PhD, FHFSA

Mechanical Circulatory Support

MCS 1: Durable MCS Devices and Outcomes — Joseph G. Rogers, MD

MCS 2: Temporary Support Devices and ECMO for the Boards — Manreet Kanwar, MD

MCS 3: Management of Complications of MCS — Manreet Kanwar, MD

MCS 4: Interactive Shock and Device Management — Daniel Burkhoff, MD, PhD; Manreet Kanwar, MD; Joseph G. Rogers, MD; Nancy Sweitzer, MD, PhD, FHFSA

Day 3 (Sunday, July 14, 2024)

Congenital & Structural Heart Disease

Adult Congenital Heart Disease for the HF Specialist — Eric V. Krieger, MD

Management of Left Sided Valvular Heart Disease in Heart Failure — Jane Wilcox, MD, MSc, FHFSA

Arrhythmia Management

Management of Common Arrhythmias 1: Atrial Fibrillation and Flutter — Roderick Tung, MD

Management of Common Arrhythmias 2: Ventricular Arrhythmia — Roderick Tung, MD

Device Therapy in Heart Failure

Device Therapy in Heart Failure I: Sudden Death Prevention — Christine Albert, MD, MPH

Device Therapy in Heart Failure II: CRT — Christine Albert, MD, MPH

Educational Experience & Learning Features

The HFSA AHFTC Board Certification Review 2024 combines advanced cardiovascular education with structured board examination preparation and clinically practical heart failure management strategies.

Original program features (not a promise of publisher account access):

• Board-focused advanced heart failure review lectures
• Recorded OnDemand presentations with flexible playback access
• Downloadable slide decks and educational materials
• Interactive ABIM-style practice question sessions
• Question bank and reading resources
• Advanced transplant cardiology education
• Mechanical circulatory support and ECMO reviews
• Hemodynamic and cardiopulmonary exercise testing discussions
• Evidence-informed arrhythmia and device therapy updates
• Comprehensive AHFTC board preparation curriculum

The curriculum integrates heart failure medicine, transplant cardiology, electrophysiology, hemodynamics, pulmonary hypertension, and critical care cardiology into a comprehensive educational platform.

Who Should Take This Course

The HFSA AHFTC Board Certification Review 2024 program is intended for clinicians involved in advanced heart failure and transplant cardiology.

This course is especially valuable for:

• Advanced heart failure cardiologists
• Transplant cardiologists
• Cardiology fellows
• Physicians preparing for the ABIM AHFTC certification examination
• Heart failure specialists
• Mechanical circulatory support clinicians
• Critical care cardiologists
• Cardiovascular advanced practice providers involved in advanced HF management

The curriculum is particularly relevant for clinicians seeking comprehensive education in advanced heart failure medicine, transplant cardiology, mechanical circulatory support, and AHFTC board preparation.

Clinical Applications & Practice Benefits

The course provides clinically relevant education focused on improving advanced heart failure management, transplant cardiology decision-making, and mechanical circulatory support strategies.

Participants gain practical insight into:

• Guideline-directed heart failure pharmacotherapy
• Hemodynamic interpretation and cardiopulmonary exercise testing
• Pulmonary hypertension classification and management
• Cardiogenic shock stabilization strategies
• Mechanical circulatory support and ECMO decision-making
• Heart transplant immunology and rejection management
• Advanced arrhythmia and device therapy approaches
• Inherited and infiltrative cardiomyopathy evaluation
• Complex inpatient and advanced HF patient management

The educational content strengthens clinical reasoning while supporting improved advanced cardiovascular care and board certification preparedness.

Professional Summary

The HFSA AHFTC Board Certification Review 2024 OnDemand program from the Heart Failure Society of America provides an educational review in advanced heart failure and transplant cardiology. Designed specifically for clinicians preparing for the ABIM AHFTC certification examinations, the curriculum combines expert-led instruction, board-style learning, and practical cardiovascular management strategies aligned with contemporary heart failure medicine.

From HFrEF, HFpEF, pulmonary hypertension, and cardiomyopathies to transplant immunology, mechanical circulatory support, ECMO, cardiogenic shock, arrhythmia management, and advanced device therapies, the program explores the full spectrum of modern advanced heart failure care.

Its integration of board preparation, hemodynamic reasoning, transplant medicine, and evidence-informed cardiovascular management makes this course a valuable educational resource for cardiologists seeking updated expertise in advanced heart failure and transplant cardiology.